Related references
Note: Only part of the references are listed.Emapalumab in Children with Primary Hemophagocytic Lymphohistiocytosis
F. Locatelli et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Consensus approach for the management of severe combined immune deficiency caused by adenosine deaminase deficiency
Donald B. Kohn et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2019)
Role of interferon-γ in immune-mediated graft failure after allogeneic hematopoietic stem cell transplantation
Pietro Merli et al.
HAEMATOLOGICA (2019)
EMAPALUMAB, AN INTERFERON GAMMA (IFN-Y)-BLOCKING MONOCLONAL ANTIBODY, IN PATIENTS WITH MACROPHAGE ACTIVATION SYNDROME (MAS) COMPLICATING SYSTEMIC JUVENILE IDIOPATHIC ARTHRITIS (SJIA)
Fabrizio De Benedetti et al.
ANNALS OF THE RHEUMATIC DISEASES (2019)
Treatment of refractory hemophagocytic lymphohistiocytosis with emapalumab despite severe concurrent infections
Dana T. Lounder et al.
BLOOD ADVANCES (2019)
Neutralization of IFN-γ reverts clinical and laboratory features in a mouse model of macrophage activation syndrome
Giusi Prencipe et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2018)
Safety and Efficacy of Emapalumab in Pediatric Patients with Primary Hemophagocytic Lymphohistiocytosis
Franco Locatelli et al.
BLOOD (2018)
Use of a mouse model to identify a blood biomarker for IFNγ activity in pediatric secondary hemophagocytic lymphohistiocytosis
Vanessa Buatois et al.
TRANSLATIONAL RESEARCH (2017)
HLA-haploidentical stem cell transplantation after removal of αβ+ T and B cells in children with nonmalignant disorders
Alice Bertaina et al.
BLOOD (2014)
ADA-deficient SCID is associated with a specific microenvironment and bone phenotype characterized by RANKL/OPG imbalance and osteoblast insufficiency
Aisha V. Sauer et al.
BLOOD (2009)
Inborn errors of interferon (IFN)-mediated immunity in humans: insights into the respective roles of IFN-alpha/beta, IFN-gamma, and IFN-lambda in host defense
Shen-Ying Zhang et al.
IMMUNOLOGICAL REVIEWS (2008)
HLH-2004: Diagnostic and therapeutic guidelines for hemophagocytic lymphohistiocytosis
Jan-Inge Henter et al.
PEDIATRIC BLOOD & CANCER (2007)
An animal model of hemophagocytic lymphohistiocytosis (HLH):: CD8+ T cells and interferon gamma are essential for the disorder
MB Jordan et al.
BLOOD (2004)
Clinical features of dominant and recessive interferon γ receptor 1 deficiencies
SE Dorman et al.
LANCET (2004)
Clinical consequences of defects in the IL-12-dependent interferon-gamma (IFN-gamma) pathway
DA Lammas et al.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2000)
Share Paper
